CMPD — CompuMed Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual income statement for CompuMed, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2008 September 30th	2009 September 30th	2010 September 30th	2011 September 30th	2012 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB/A	10-K	10-K	ARS	PRESS
Standards:	USG	USG	USG	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2.15	2.05	1.76	1.68	1.65
Cost of Revenue
Gross Profit	1.24	1.29	1.02	0.879	0.862
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	3.54	2.25	2.11	1.98	1.76
Operating Profit	-1.39	-0.202	-0.348	-0.302	-0.111
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1.48	-0.253	-0.378	-0.223	-0.07
Provision for Income Taxes
Net Income After Taxes	-1.48	-0.253	-0.378	-0.223	-0.07
Net Income Before Extraordinary Items
Net Income	-1.48	-0.253	-0.378	-0.223	-0.07
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1.52	-0.296	-0.467	-0.295	-0.105
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1.5	-0.284	-0.435	-0.269	-0.094
Dividends per Share